PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.45%
Revenue growth above 1.5x 3141.T's 5.32%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
8.06%
Gross profit growth at 50-75% of 3141.T's 11.08%. Martin Whitman would question if cost structure or brand is lagging.
14.43%
EBIT growth below 50% of 3141.T's 37.91%. Michael Burry would suspect deeper competitive or cost structure issues.
17.38%
Operating income growth under 50% of 3141.T's 89.40%. Michael Burry would be concerned about deeper cost or sales issues.
50.76%
Net income growth 1.25-1.5x 3141.T's 45.60%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
50.77%
EPS growth 1.25-1.5x 3141.T's 45.48%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
50.77%
Diluted EPS growth 1.25-1.5x 3141.T's 45.55%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
35.29%
Dividend growth of 35.29% while 3141.T is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
6.12%
OCF growth above 1.5x 3141.T's 4.05%. David Dodd would confirm a clear edge in underlying cash generation.
6.12%
FCF growth above 1.5x 3141.T's 4.05%. David Dodd would verify if the firm’s strategic investments yield superior returns.
25.67%
10Y revenue/share CAGR under 50% of 3141.T's 162.94%. Michael Burry would suspect a lasting competitive disadvantage.
50.38%
5Y revenue/share CAGR at 75-90% of 3141.T's 64.35%. Bill Ackman would encourage strategies to match competitor’s pace.
15.60%
3Y revenue/share CAGR under 50% of 3141.T's 31.23%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
64.86%
Below 50% of 3141.T's 157.09%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
30.47%
5Y net income/share CAGR at 50-75% of 3141.T's 43.94%. Martin Whitman might see a shortfall in operational efficiency or brand power.
4.42%
Positive short-term CAGR while 3141.T is negative. John Neff would see a clear advantage in near-term profit trajectory.
134.80%
10Y equity/share CAGR at 50-75% of 3141.T's 259.84%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
93.84%
5Y equity/share CAGR 1.25-1.5x 3141.T's 73.25%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
44.89%
3Y equity/share CAGR 1.25-1.5x 3141.T's 39.33%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
283.33%
10Y dividend/share CAGR at 50-75% of 3141.T's 412.00%. Martin Whitman suspects the firm lags in returning cash to shareholders over the decade.
155.56%
5Y dividend/share CAGR above 1.5x 3141.T's 52.38%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
91.67%
3Y dividend/share CAGR above 1.5x 3141.T's 18.52%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
32.94%
Our AR growth while 3141.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
10.47%
We show growth while 3141.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
11.68%
Positive asset growth while 3141.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
3.71%
1.25-1.5x 3141.T's 3.10%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
187.81%
We have some new debt while 3141.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-39.78%
We cut SG&A while 3141.T invests at 3.51%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.